These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 29151909)
1. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway. Li M; Liang RF; Wang X; Mao Q; Liu YH Oncol Lett; 2017 Dec; 14(6):6597-6603. PubMed ID: 29151909 [TBL] [Abstract][Full Text] [Related]
2. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway. Tang Q; Cao H; Tong N; Liu Y; Wang W; Zou Y; Xu L; Zeng Z; Xu W; Yin Z; Ma W; Wang Q Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900 [TBL] [Abstract][Full Text] [Related]
3. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway. Hu YH; Jiao BH; Wang CY; Wu JL CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245 [TBL] [Abstract][Full Text] [Related]
4. Quercetin induces MGMT Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182 [TBL] [Abstract][Full Text] [Related]
6. Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition. Kundu M; Das S; Nandi S; Dhara D; Mandal M Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166782. PubMed ID: 37286145 [TBL] [Abstract][Full Text] [Related]
7. Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells. Song T; Li H; Tian Z; Xu C; Liu J; Guo Y Onco Targets Ther; 2015; 8():2199-208. PubMed ID: 26346978 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway. Huang H; Lin H; Zhang X; Li J Oncol Rep; 2012 Jun; 27(6):2050-6. PubMed ID: 22426504 [TBL] [Abstract][Full Text] [Related]
9. NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells. Wang X; Jia L; Jin X; Liu Q; Cao W; Gao X; Yang M; Sun B Oncol Lett; 2015 Jun; 9(6):2586-2590. PubMed ID: 26137111 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of O Happold C; Stojcheva N; Silginer M; Weiss T; Roth P; Reifenberger G; Weller M J Neurochem; 2018 Mar; 144(6):780-790. PubMed ID: 29480969 [TBL] [Abstract][Full Text] [Related]
11. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068 [TBL] [Abstract][Full Text] [Related]
12. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512 [TBL] [Abstract][Full Text] [Related]
13. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
14. Pyrrolidine dithiocarbamate sensitizes U251 brain glioma cells to temozolomide via downregulation of Tang JH; Huang GH; Mou KJ; Zhang EE; Li N; Du L; Zhu XP; Chen L; Yang H; Zhang KB; Lv SQ Oncol Lett; 2017 Nov; 14(5):5135-5144. PubMed ID: 29098021 [TBL] [Abstract][Full Text] [Related]
15. A steroidal saponin form Paris vietnamensis (Takht.) reverses temozolomide resistance in glioblastoma cells via inducing apoptosis through ROS/PI3K/Akt pathway. Zhang S; Lu Y; Li H; Ji Y; Fang F; Tang H; Qiu P Biosci Trends; 2020 May; 14(2):123-133. PubMed ID: 32173672 [TBL] [Abstract][Full Text] [Related]
16. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]